Greg Brockman @gdb

towards acceleration of drug development, an extremely exciting and promising emerging application of our models [引用 @OpenAI]: We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://t.co/vi51OhznQn

• OpenAI's Brockman Withdraws Second $25M Donation to AI Super PAC2026-09-30
• OpenAI Has Gone Nine Months Without a Communications Chief2026-09-28
• OpenAI's Brockman Optimistic About AI2026-09-17
• OpenAI President on Lessons After Hugging Face Incident2026-09-14